Therapeutic heterocycles

Details Therapeutic heterocycles Therapeutic heterocycles

2006-05-30

2006-05-30

O'Sullivan, Peter (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Chalcogen in the nitrogen containing substituent

C544S317000, C546S209000, C546S210000

Reexamination Certificate

active

07053213

ABSTRACT:
Pharmaceutical compositions containing novel therapeutic heterocycles for use in diseases in which an NK2 receptor is implicated, processes for preparing and methods for using the same.

REFERENCES:
patent: 5236921 (1993-08-01), Emonds-Alt et al.
patent: 5559131 (1996-09-01), Miller
patent: 5559132 (1996-09-01), Miller
patent: 5567700 (1996-10-01), Miller
patent: 5576333 (1996-11-01), Miller
patent: 5602138 (1997-02-01), Miller
patent: 5861392 (1999-01-01), Miller
patent: 5990130 (1999-11-01), Miller
patent: 6444809 (2002-09-01), Miller
patent: 2029275 (1991-05-01), None
patent: 2067924 (1992-11-01), None
patent: 2090785 (1993-09-01), None
patent: 0428434 (1991-05-01), None
patent: 0474561 (1992-03-01), None
patent: 0512901 (1992-11-01), None
patent: 0512902 (1992-11-01), None
patent: 0515240 (1992-11-01), None
patent: 0515250 (1992-11-01), None
patent: 0559538 (1993-09-01), None
patent: WO 91/09844 (1991-07-01), None
patent: WO 94/10146 (1994-05-01), None
patent: 923177 (1993-01-01), None
patent: 923178 (1993-01-01), None
A. Graham et al., “Isolaton and Characterisation of the Human Lung NK-2 Receptor Gene Using Rapid Amplification of cDNA Ends”,Biochemical and Biophysical Research Communications, (1991), vol. 177, No. 1, 8-16.
X. Emonds-Alt et al., “Pharmacological Profile and Chemical Synthesis of SR 48968, a Non-Peptide Antagonist of the Neurokinin A (NK2) Receptor”,Biorganic&Medicinal Chemistry Letters, (1993), vol. 3, No. 5, 925-930.
D. Aharony et al., “Pharmacologic Characterization of the Novel Ligand [4, 5-3H-LEU9] Neurokinin-A Binding to NK-2 Receptors on Hamster Urinary Bladder Membranes”,Neuropeptides, (1992), 23, 121-130.
M. Needham et al., “LCR/MEL: A Versatile System for High-Level Expression of Heterologous Proteins in Erythroid Cells”,Nucleic Acids Research, (1992), vol. 20, No. 5, 997-1003.

Affiliated with

Also associated with

Rating

Therapeutic heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic heterocycles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3559952